US Patent Issued to Compass Therapeutics on April 29 for "Method of treating cancer using CD137 antibodies and PD-1 antagonists" (Massachusetts Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,286,483, issued on April 29, was assigned to Compass Therapeutics LLC (Cambridge, Mass.).

"Method of treating cancer using CD137 antibodies and PD-1 antagonists" was invented by Ugur Eskiocak (Somerville, Mass.) and Robert V. Tighe III (North Reading, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to combinations of antibodies, or antigen-binding fragments thereof, that bind to CD137, and PD-1 antagonists. The disclosure also relates to methods for treating or ameliorating one or more symptoms of a disease, such as cancer, by administering the combination."

The patent was filed on May 25, 2023, under Application No. ...